New Fields of Clinical Application of Proton Pump Inhibitor
10.3969/j.issn.1008-7125.2017.11.010
- VernacularTitle:质子泵抑制剂临床应用新领域
- Author:
Qi SHANG
1
;
Lifang GUO
;
Cuixia ZHANG
;
Meng WEN
;
Yun LI
;
Yuefei YIN
;
Yali CHEN
;
Dekui ZHANG
Author Information
1. 兰州大学第二医院消化科 730030
- Keywords:
Proton Pump Inhibitors;
Neoplasms;
Pulmonary Fibrosis;
Atrial Fibrillation;
Premature Birth;
Therapy
- From:
Chinese Journal of Gastroenterology
2017;22(11):696-699
- CountryChina
- Language:Chinese
-
Abstract:
Proton pump inhibitor (PPI) is the first-line drug for treatment of abnormal secretion of gastric acid and acid related diseases,and is effective in the treatment of peptic ulcer,Helicobacter pylori (Hp) infection,upper gastrointestinal bleeding and gastroesophageal reflux disease (GERD).Recent studies have shown that PPI could be used in other clinical fields,such as tumor,pulmonary fibrosis,atrial fibrillation,tuberculosis infection and premature delivery,which provides new insights for the treatment of these diseases.This article reviewed the new fields of clinical application of PPL.
